COVID News: Study finds Pfizer vaccine safe for most allergy sufferers
More than 97% of high-risk patients had no immediate allergic reaction after the first dose of the vaccine.
More than 97% of high-risk patients had no immediate allergic reaction after the first dose of the vaccine.